Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PlantPharm BioMed's HPV vaccine is an investigational plant-based oral solid dose vaccine designed to prevent or treat Human Papillomavirus (HPV)-related diseases. Utilizing a proprietary platform, the vaccine expresses HPV antigens within plant tissues, which are then processed into a stable, oral format. This approach aims to simplify vaccine distribution by eliminating the need for refrigeration and needle-based administration. The vaccine works by delivering plant-produced antigens to the gut-associated lymphoid tissue (GALT), triggering both mucosal and systemic immune responses to protect against HPV infection and associated pathologies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on HPV oral vaccine (PlantPharm BioMed).